Updates are available Correction dated 2025-08-11
Click to view Correction: https://doi.org/10.1038/s41588-025-02328-6
-
Authors
Uryu, Hidetaka
Saeki, Koichi https://orcid.org/0000-0003-1886-8302
Haeno, Hiroshi https://orcid.org/0000-0002-6211-0649
Kapadia, Chiraag Deepak https://orcid.org/0000-0003-1805-8879
Furudate, Ken https://orcid.org/0000-0003-1272-5490
Nangalia, Jyoti https://orcid.org/0000-0001-7122-4608
Spencer Chapman, Michael https://orcid.org/0000-0002-5320-8193
Zhang, Linda
Padilla, Jennifer
Zhao, Li
Hsu, Joanne I.
Zhao, Chong
Chen, Shujuan
Tanaka, Tomoyuki
Li, Zongrui
Ogata, Satoko https://orcid.org/0000-0002-0169-3959
Hanache, Sarah
Yang, Hui
DiNardo, Courtney https://orcid.org/0000-0001-9003-0390
Daver, Naval https://orcid.org/0000-0001-7103-373X
Pemmaraju, Naveen
Jain, Nitin https://orcid.org/0000-0003-0114-8384
Ravandi, Farhad https://orcid.org/0000-0002-7621-377X
Zhang, Jianhua https://orcid.org/0000-0001-5412-9860
Song, Xingzhi
Thompson, Erika
Tang, Hongli
Little, Latasha
Gumbs, Curtis
Orlowski, Robert Z. https://orcid.org/0000-0002-5723-4129
Qazilbash, Muzaffar
Bhalla, Kapil https://orcid.org/0000-0001-5209-5126
Colla, Simona https://orcid.org/0000-0001-6583-8910
Kantarjian, Hagop https://orcid.org/0000-0002-1908-3307
Kanagal-Shamanna, Rashmi https://orcid.org/0000-0001-7829-5249
Bueso-Ramos, Carlos https://orcid.org/0000-0003-0180-7124
Nakada, Daisuke https://orcid.org/0000-0001-6010-7094
Al-Atrash, Gheath https://orcid.org/0000-0002-7648-4377
Molldrem, Jeffery
Futreal, P. Andrew https://orcid.org/0000-0001-8663-2671
Shpall, Elizabeth
Goodell, Margaret https://orcid.org/0000-0003-1111-2932
Garcia-Manero, Guillermo https://orcid.org/0000-0002-3631-2482
Takahashi, Koichi https://orcid.org/0000-0002-8027-9659
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA237291, R01CA262636, P01CA265748, R01CA237291, P01CA265748)
Leukemia and Lymphoma Society
- License Information
-
More Information
Article History
Received: 13 July 2024
Accepted: 16 May 2025
First Online: 1 July 2025
Change Date: 11 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-025-02328-6
Competing interests
: C.D. receives research support (to institution) from AbbVie, Agios, Bayer, Calithera, Cleave, BMS/Celgene, Daiichi Sankyo and ImmuneOnc and is among the consultant/advisory boards at AbbVie, Agios, Celgene/BMS, Daiichi Sankyo, ImmuneOnc, Novartis, Takeda and Notable Labs. H.K. receives research grants from AbbVie, Amgen, Ascentage, BMS, Daiichi Sankyo, Immunogen, Jazz, Novartis, Pfizer and Sanofi, and receives honoraria from AbbVie, Actinium, Adaptive Biotechnologies, Amgen, Apptitude Health, BioAscend, Daiichi Sankyo, Delta Fly, Janssen Global, Novartis, Oxford Biomedical, Pfizer and Takeda. K.T. has received consulting fees from Celgene, GSK and Novartis. He is on the scientific advisory board for Symbio Pharmaceuticals. The other authors declare no competing interests.
